PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Budesonide - Inflammatory bowel disease
PAD Profile : Budesonide - Inflammatory bowel disease Important
Keywords :
Ulcerative colitis, UC, IBD, protitis, procto sigmoiditis
Brand Names Include :
Budenofalk
Important Information :
Steroid safety considerations
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
Type
Document
Review Date
Safety Information
Committee Recommendations
Date
Committee Name
Narrative
07 February 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Please see the attached pathway which has been developed in conjunction with local specialists for the GP management of adult patients with known ulcerative colitis .
13 March 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN recommends Budenofalk (budesonide) rectal foam as a treatment option for patients with active Ulcerative Colitis
Budenofalk (budesonide) rectal foam will be considered GREEN on the traffic light system
Primary care prescribers should consider switching patients to budesonide rectal foam and for all new patients to use budesonide rectal foam moving forwards.
Associated BNF Codes
01. Gastro-Intestinal System
01.05.02. Corticosteroids